~7 spots leftby Jun 2026

AquaLumen Filtration Procedure for Glaucoma

Recruiting in Palo Alto (17 mi)
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: PLU Ophthalmic
No Placebo Group

Trial Summary

What is the purpose of this trial?

The study will follow a group of patients with glaucoma disease that undergo a surgical procedure intended to reduce the intra-ocular pressure (IOP) for a period of one year.

Research Team

Eligibility Criteria

This clinical trial is for individuals with a condition called Open Angle Glaucoma, which increases pressure inside the eye. Participants should be those who require treatment to lower this pressure and are willing to undergo surgery.

Inclusion Criteria

Central corneal thickness between 480 and 610 microns
I have moderate to severe open angle glaucoma.

Exclusion Criteria

I have cloudy areas on my cornea.
I have had a corneal transplant surgery.
I had a trabeculectomy that did not work.

Treatment Details

Interventions

  • AquaLumen (Procedure)
Trial OverviewThe study is testing a new surgical procedure called AquaLumen designed to reduce intra-ocular pressure in patients with Open Angle Glaucoma. The effectiveness and safety of this procedure will be monitored over one year.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: This is the group that will undergo the surgical treatmentExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

PLU Ophthalmic

Lead Sponsor

Trials
1
Recruited
10+